TL;DR:
- Sorcero unveils Fall ’23 Release of the AI Platform for Life Sciences.
- New additions: Sorcero iSLR™ for systematic literature reviews and Sorcero PLS™ for plain language summaries.
- Accelerates evidence generation by up to 90%, improving patient outcomes.
- Enhances omnichannel analytics for more effective Key Opinion Leader (KOL) engagement.
- AI-based content labeling identifies critical topics such as safety and efficacy.
- CEO Dipanwita Das participates in a pivotal AI-focused webinar with Reuters.
Main AI News:
In an exciting development for Life Sciences organizations, Sorcero, the leading provider of advanced AI solutions, has unveiled the Fall ’23 Release of the Sorcero AI Platform. This release marks a significant expansion of capabilities, with the introduction of Sorcero iSLR™ for Systematic Literature Review and Sorcero PLS™ for Plain Language Summaries. These additions empower Medical Affairs teams to unearth valuable insights from an array of sources in record time, ultimately leading to enhanced patient outcomes.
Traditionally, extracting insights from scientific data has been a labor-intensive, manual process. The ever-expanding array of data sources, including publications, healthcare provider data, surveys, KOL engagement platforms, and structured datasets, has only compounded the challenges faced by Medical Affairs teams. Sorcero’s AI-driven solutions come to the rescue, enabling these teams to discover insights that can make a tangible difference in patient outcomes. Sorcero transforms data into valuable assets, eliminating the burden of data liabilities.
Here are the key highlights of the Fall ’23 Release of the Sorcero AI Platform:
- Sorcero iSLR: This cutting-edge addition empowers intelligent systematic literature reviews, significantly accelerating evidence generation, up to 90% faster than conventional methods. This acceleration translates into quicker timelines for the development and delivery of life-changing therapies to patients in need.
- Sorcero PLS: Sorcero has revolutionized the production of abstracts and publication companion plain language summaries, tailoring them to specific audiences. This innovation not only reduces production time but also sets new standards in accessibility and adherence to FDA regulatory requirements.
- Enhanced Omnichannel Analytics: Medical Affairs teams can now filter and segment Key Opinion Leaders (KOLs) based on their interactions with the company and their scientific contributions, enabling more effective engagement strategies.
- AI-Based Content Labeling: The Sorcero AI Platform’s library of AI-powered enrichments continues to expand, intelligently identifying discussions and concerns about critical topics such as safety and efficacy. This goes beyond what traditional NLP approaches can achieve.
Dipanwita Das, CEO, and co-founder of Sorcero, emphasized, “Our philosophy has always centered on improving patient outcomes. With Sorcero’s AI platform, Medical Affairs teams can harness the wealth of biomedical data to accelerate the adoption of life-saving therapies.”
Nithi Vivatrat, Chief Product Officer at Sorcero, added, “As Medical Affairs expands its strategic responsibilities, they require purpose-built tools. This release enhances Sorcero’s capabilities to facilitate collaborative evidence-building, expedite medical insights discovery, and streamline data and report exports for internal business processes.”
The Sorcero AI Platform encompasses four products: Sorcero IPM™, Sorcero MIM™, Sorcero PLS™, and Sorcero iSLR™, each tailored to meet the specific needs of Life Sciences organizations.
- Sorcero IPM (Intelligent Publication Management) identifies clinically impactful content from an extensive dataset of open-access scientific sources, supporting competitive intelligence, compliance, and evidence generation.
- Sorcero MIM (Medical Insight Management) unifies evidence from internal and external sources, offering data exploration, evidence collection, and automated recommendations to enhance patient outcomes, raise awareness, and track impact. It eliminates information silos and delivers 300% more insight data while drastically reducing the time needed to spot emerging trends.
- Sorcero PLS (Plain Language Summaries) Service simplifies the generation of plain language deliverables, ensuring they comply with regulations and engage broader audiences. This solution transforms complex scientific and medical data into easily understandable language.
- Sorcero iSLR (Intelligent Systematic Literature Review) enhances the scalability of evidence generation for teams focused on efficacy, safety, and value evidence. With collaboration tools and AI-enhanced workflows, these teams gain access to high-quality evidence for informed decision-making and product adoption.
Conclusion:
Sorcero’s Fall ’23 Release signifies a game-changing advancement for the Life Sciences market. By enabling faster evidence generation, more efficient content production, and enhanced analytics, Sorcero empowers Medical Affairs teams to make informed decisions and accelerate the adoption of life-saving therapies, ultimately driving growth and innovation in the industry.
